SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-24-002651
Filing Date
2024-03-28
Accepted
2024-03-28 11:02:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 5290
  Complete submission text file 0001959173-24-002651.txt   6729
Mailing Address 780 BRANNAN STREET SAN FRANCISCO CA 94103
Business Address 780 BRANNAN STREET SAN FRANCISCO CA 94103 (415) 651-3316
Olema Pharmaceuticals, Inc. (Subject) CIK: 0001750284 (see all company filings)

IRS No.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39712 | Film No.: 24795227
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O OLEMA PHARMACEUTICALS, INC. 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107
Business Address
Harmon Cyrus (Reporting) CIK: 0001831410 (see all company filings)

Type: 144